Shivalik Rasayan Ltd

Shivalik Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shivalik Rasayan Ltd

₹ 663 6.01%
24 Mar - close price
shivalikrasayan.com BSE: 539148 NSE : SHIVALIK
About

The company is into manufacturing of agrochemicals and in 2015 it forayed into pharmaceuticals.
The company acquired Medicamen Biotech Limited in 2015 which is engaged in manufacturing pharmaceutical formulations. [1] [2]

Key Points

Business Segments
Shivalik Rasayan is into 2 business segments :

Website BSE NSE
  • Market Cap ₹ 961 Cr.
  • Current Price ₹ 663
  • High / Low ₹ 1,107 / 614
  • Stock P/E 41.5
  • Book Value ₹ 194
  • Dividend Yield 0.08 %
  • ROCE 15.0 %
  • ROE 11.0 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has delivered good profit growth of 24.8% CAGR over last 5 years

Cons

  • The company has delivered a poor sales growth of 11.7% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 9.84% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
51.28 37.77 46.01 52.40 55.85 43.32 50.39 56.69 59.53 48.14 57.83 56.33 57.36
43.50 31.24 39.52 43.55 44.18 32.36 37.86 44.69 47.60 37.84 45.99 45.32 47.38
Operating Profit 7.78 6.53 6.49 8.85 11.67 10.96 12.53 12.00 11.93 10.30 11.84 11.01 9.98
OPM % 15.17% 17.29% 14.11% 16.89% 20.90% 25.30% 24.87% 21.17% 20.04% 21.40% 20.47% 19.55% 17.40%
0.45 1.10 0.21 0.13 0.23 0.55 0.08 0.48 1.30 1.85 1.45 0.85 1.46
Interest 0.36 0.25 0.25 0.56 0.27 0.50 0.36 0.52 0.74 0.89 1.03 0.88 1.07
Depreciation 0.84 1.11 1.65 1.79 3.03 2.11 2.60 2.64 2.92 2.85 3.01 2.83 2.95
Profit before tax 7.03 6.27 4.80 6.63 8.60 8.90 9.65 9.32 9.57 8.41 9.25 8.15 7.42
Tax % 19.20% 14.67% 19.58% 19.76% 16.16% 4.49% 5.28% 7.62% 12.64% 3.09% 8.54% 6.26% 10.24%
Net Profit 5.68 5.35 3.87 5.31 7.20 8.50 9.14 8.61 8.37 8.14 8.46 7.65 6.65
EPS in Rs 2.50 2.79 1.82 2.44 3.90 4.77 4.88 4.44 4.28 4.51 4.40 3.82 3.27
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
41 110 123 155 171 186 198 215 220
38 99 105 131 147 157 159 167 177
Operating Profit 3 10 18 24 24 29 38 47 43
OPM % 7% 9% 15% 16% 14% 16% 19% 22% 20%
0 1 1 3 8 3 1 4 6
Interest 0 5 6 4 3 2 2 3 4
Depreciation 0 2 2 2 3 4 9 11 12
Profit before tax 3 5 11 20 26 27 29 37 33
Tax % 33% 33% 25% 25% 20% 17% 15% 7%
Net Profit 2 3 8 15 21 22 25 34 31
EPS in Rs 2.10 3.66 9.84 14.39 9.88 10.17 12.77 17.68 16.00
Dividend Payout % 0% 0% 4% 3% 5% 2% 4% 3%
Compounded Sales Growth
10 Years: %
5 Years: 12%
3 Years: 8%
TTM: 5%
Compounded Profit Growth
10 Years: %
5 Years: 25%
3 Years: 23%
TTM: -9%
Stock Price CAGR
10 Years: %
5 Years: 18%
3 Years: 46%
1 Year: -24%
Return on Equity
10 Years: %
5 Years: 12%
3 Years: 10%
Last Year: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
3 3 3 4 7 7 7 7 7
Reserves 8 11 7 45 158 169 172 280 274
0 31 32 22 20 10 29 38 46
11 36 52 81 103 142 155 163 192
Total Liabilities 23 81 94 152 288 328 363 488 520
7 27 27 40 41 52 210 221 219
CWIP 0 0 0 0 26 102 0 3 11
Investments 0 0 0 0 0 0 0 0 0
16 53 66 111 222 175 153 264 289
Total Assets 23 81 94 152 288 328 363 488 520

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
4 12 8 -7 -8 6 59 11
-0 -18 -4 -24 -24 -102 -65 -23
1 3 -3 52 100 10 2 78
Net Cash Flow 4 -3 2 21 69 -86 -4 66

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 80 77 92 108 111 114 127 119
Inventory Days 5 64 76 65 71 65 34 148
Days Payable 126 152 137 103 123 171 152 216
Cash Conversion Cycle -41 -11 31 71 59 7 9 51
Working Capital Days -11 36 52 107 147 160 98 146
ROCE % 33% 39% 43% 22% 15% 16% 15%

Shareholding Pattern

Numbers in percentages

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
52.92 52.92 52.92 52.92 52.92 52.92 52.92 50.32 50.32 50.32 50.32 50.32
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.04 0.01 0.01
47.08 47.08 47.08 47.08 47.08 47.08 47.08 49.68 49.62 49.64 49.67 49.67

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • Dec 2021
    Transcript
    Notes
    PPT
  • Sep 2021
    Transcript
    Notes
    PPT
  • Aug 2020
    Transcript
    Notes
    PPT
  • Dec 2019
    Transcript
    Notes
    PPT
  • Dec 2019
    Transcript
    Notes
    PPT